99 related articles for article (PubMed ID: 1354430)
1. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas.
Volm M; Mattern J; Efferth T; Pommerenke EW
Anticancer Res; 1992; 12(4):1063-7. PubMed ID: 1354430
[TBL] [Abstract][Full Text] [Related]
2. Associated expression of protein kinase C with resistance to doxorubicin in human lung cancer.
Volm M; Pommerenke EW
Anticancer Res; 1995; 15(2):463-6. PubMed ID: 7763022
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
Volm M
Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
5. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
6. Chemoresistance to doxorubicin and cisplatin in a murine cell line. Analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes.
Mestdagh N; Pommery N; Saucier JM; Hecquet B; Fournier C; Slomianny C; Teissier E; Hénichart JP
Anticancer Res; 1994; 14(3A):869-74. PubMed ID: 7915509
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
[TBL] [Abstract][Full Text] [Related]
8. Cellular predictive factors for the drug response of lung cancer.
Volm M; Rittgen W
Anticancer Res; 2000; 20(5B):3449-58. PubMed ID: 11131647
[TBL] [Abstract][Full Text] [Related]
9. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
10. Prediction of drug resistance in human tumors using immunohistochemical techniques.
Mattern J; Volm M
Anticancer Res; 1992; 12(2):413-8. PubMed ID: 1349793
[TBL] [Abstract][Full Text] [Related]
11. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin.
Rappa G; Lorico A; Sartorelli AC
Cancer Res; 1993 Nov; 53(22):5487-93. PubMed ID: 8106148
[TBL] [Abstract][Full Text] [Related]
12. Detection of multidrug resistance associated P-170 glycoprotein in previously untreated non small cell lung cancer.
Scagliotti GV; Michelotto F; Kalikatzaros G; Leonardo E; Cappia S; Gubetta L; Borasio P; Pozzi E
Anticancer Res; 1991; 11(6):2207-10. PubMed ID: 1685647
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors.
Efferth T; Mattern J; Volm M
Oncology; 1992; 49(5):368-75. PubMed ID: 1356260
[TBL] [Abstract][Full Text] [Related]
14. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.
Cole SP; Chanda ER; Dicke FP; Gerlach JH; Mirski SE
Cancer Res; 1991 Jul; 51(13):3345-52. PubMed ID: 1675932
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers.
Volm M; Mattern J; Samsel B
Br J Cancer; 1991 Oct; 64(4):700-4. PubMed ID: 1680367
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
Long BH; Wang L; Lorico A; Wang RC; Brattain MG; Casazza AM
Cancer Res; 1991 Oct; 51(19):5275-83. PubMed ID: 1717144
[TBL] [Abstract][Full Text] [Related]
17. Detection of resistance proteins in matched primary lung tumors and lymph node metastases.
Mattern J; Volm M
Anticancer Res; 1994; 14(2A):417-9. PubMed ID: 7912493
[TBL] [Abstract][Full Text] [Related]
18. Expression of drug resistance gene products during progression of lung carcinomas.
Mattern J; Koomägi R; Volm M
Oncol Rep; 2002; 9(6):1181-4. PubMed ID: 12375015
[TBL] [Abstract][Full Text] [Related]
19. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M; Kästel M; Mattern J; Efferth T
Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
[TBL] [Abstract][Full Text] [Related]
20. Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer.
Shin HJ; Lee JS; Hong WK; Shin DM
Anticancer Res; 1992; 12(2):367-70. PubMed ID: 1374598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
